Karen A. Flynn
2017
In 2017, Karen A. Flynn earned a total compensation of $1.9M as SVP & Chief Commercial Officer at West Pharmaceutical Services, a 21% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $112,801 |
|---|---|
| Non-Equity Incentive Plan | $281,904 |
| Option Awards | $499,952 |
| Salary | $469,615 |
| Stock Awards | $500,069 |
| Other | $38,306 |
| Total | $1,902,647 |
Flynn received $500.1K in stock awards, accounting for 26% of the total pay in 2017.
Flynn also received $112.8K of change in pension value and nonqualified deferred compensation earnings, $281.9K in non-equity incentive plan, $500K in option awards, $469.6K in salary and $38.3K in other compensation.
Rankings
In 2017, Karen A. Flynn's compensation ranked 5,745th out of 14,666 executives tracked by ExecPay. In other words, Flynn earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,745 out of 14,666 | 61st |
Division Manufacturing | 2,088 out of 5,772 | 64th |
Major group Rubber And Miscellaneous Plastics Products | 45 out of 105 | 57th |
Industry group Fabricated Rubber Products, Not Elsewhere | 8 out of 19 | 58th |
Source: SEC filing on March 22, 2019.
Flynn's colleagues
We found four more compensation records of executives who worked with Karen A. Flynn at West Pharmaceutical Services in 2017.